Key points are not available for this paper at this time.
Area-level measures of sociodemographic disadvantage may be associated with racial and ethnic disparities with respect to receipt of treatment for metastatic renal cell carcinoma (mRCC) but have not been investigated previously, to our knowledge.
Rahman et al. (Tue,) studied this question.